Summary: The sequence of reactions catalyzed by uricase, catalase and aldehyde dehydrogenase for determination of the uric acid concentration was evaluated for human serum and urine samples. More than 60 substances were tested for possible interferences. Alcohol dehydrogenase, formaldehyde and homogentisic acid can disturb the proposed assay, but at concentrations which are not usually encountered in human serum or urine. In the presence of protein at least 99% of the uric acid was recovered.
Introduction
The uricase reaction is now widely used for the specific determination of uric acid in biological materials. This reaction can either be recorded directly at 293 nm or indicated by various procedures which utilize the H 2 0 2 produced.
In the method öfKageyama (1), the 2 ? , in the presence of methanol and catalase, is converted into formaldehyde and H 2 O. The formaldehyde is coupled with acetylaeetone to form 1,3-dihydrplutidine. This procedure has 2 disadvantages: it proceeds very slowly, even at 37 °C, and the extinction coefficient of the colour formed is unknown.
Recently, the aldehyde dehydrogenase reaction was proposed as an indicator for the aldehyde formed by the catalase reaction (2, 
Results

Reaction velocity
Under the experimental conditions mentioned above the amount of uricase was not optimal with respect to the reaction velocity. The reaction can be speeded up by adding more uricase ( fig. 1 ). The amount of aldehyde dehydrogenase chosen did not limit the overall reaction velocity with the uricase activities used ( fig. 2 ).
Before starting the assay and after the endpoint of the uricase reaction is reached a slight endogeneous reaction (A = 0.001-0.002/min) is usually observed. With some control sera and sera from patients suffering, for instance, from acute hepatitis, a slight reverse reaction can lead to slightly erroneous results if neglected. This effect can be avoided by using NADP* instead of NAD purposes. Some authors report sensitivity in terms of absorbance signal per concentration (8) . A concentration of 500 μιηοΐ/ΐ uric acid yields an absorbance of 0.27atHg334nm.
Interferences
An extensive study for interference was undertaken as no results with the aldehyde dehydrogenase reaction in human sera have been reported so far. No interference from bilirubin, hemoglobin and ascorbic acid was found (tab. 3). Samples containing a triglyceride concentration above 10 mmol/1 should not be analyzed with the mechanized procedure because of a high blank absorbance value (approximately 1.0-1.5 at Hg 334 nm).
Further studies were undertaken with a series of drugs as described in a preceeding report (9) . No interference by these substances was noticed (tab. 4).
During this study we noticed that in the urine from an alcaptonuric patient less uric acid was found with the method reported above than was excreted. This effect is caused by a decomposition of homogentisic acid at pH 8.5 which can be observed at Hg 334 nm ( fig. 5 ).
This pH value was chosen as a compromise between the pH-optima of all enzymes applied. The interference from homogentisic acid can be avoided by chosing a lower pH value. At pH 7.0 the homogentisic acid is stable, but the NADPH is formed more slowly ( fig. 5 ).
A possible interference from alcohol dehydrogenase which is released into the blood stream during acute liver diseases (10,11) was investigated by adding various amounts of this enzyme to the proposed assay ( fig. 6 ).
In the presence of alcohol dehydrogenase a continuous increase of absorbance is observed which is accelerated with the amount of the enzyme added to the reaction mixture. Under the condition of the proposed assay the alcohol dehydrogenase reaction does not proceed linearfly. Therefore, extrapolation of the absorbance reading to the start of the aldehyde dehydrogenase reaction (when uncase is added) leads to a slight overestimation of the uric acid concentration (approximately + 12% in figure  6 ). This effect is less pronounced if NADP + is used instead of NAD + ( fig. 6 ) and can be avoided with the sample blank method. However, such high activities of alcohol dehydrogenase presumably never occur in human serum (10, 11) .
Under the proposed assay conditions there was only a slight production of NADPH in the presence of formaldehyde, which caused an absorbance increase of 0.02/ min at Hg 334 run. The resulting higher "endogenous rate" has no influence on the recovery of uric acid.
An interference of the uric acid determination as sug» gested above could be expected from inhibitors of the aldehyde dehydrogenase such as calciumcarbimidum (calcium cyanamide, trade name: dispan), phenylbutazonum (butazolidin, trade name irgapyrin), disulfirajn (trade name antabus, no effect up to 1 mmol/1), butyraldoxim or sulfonylureas (12) . the concentrations of these drugs needed for significant inhibition of the aldehyde dehydrogenase aire usually not encountered in human sera. In table 5 the concentration of uric acid determined with the aldehyde dehydrogenase-, the Kageyama-and the UV-procedure are reported for some sera containing high creatinine concentrations.
Urine samples
As reported in a proceeding communication (9) the Kageyama method can be used to determine the uric acid concentration in human urine. Therefore, the uric acid was measured with this procedure and the method described above. The results from both methods correlate well ( fig. 7) . Urine samples were prediluted 1 + 10 with bidist. wacer.
Discussion
The use of catalase and aldehyde dehydrogenase to determine the uricase reaction appears to be a suitable principle for the routine laboratory in clinical chemistry. In comparison with the UV-method, which measures the decomposition of uric acid directly a.t 293 nm, it has the advantages of -higher sensitivity, -that it avoids the glycerol effect (13) and -that it employs the NADH or NADPH band which can be detected by most photometers used in routine laboratories. 510  757  659  702  598  763  890  1162  966  811  806  1165  1204  1040  811  1060  1099  658  573  895  1344  521  500  889  876  1216  1390   a   )  mean value   Uric acid (μπιο1/1|  I   302  608  257  593  380  345  381  481  346  483  433  400  439  368  472  394  448  371  267  462  484  414  332  433  544  364  422  318  398   II   297  677  254  554  362  313  402  506  353  482  467  385  434  335  463  386  463  321  309  457  523  465  396  418  511  364  372  291  399   III   304  646  258  578  357  342  402  495  359  491  430  388  459  376  484  417  467  338  326  462  486  414  348  445  527  377  380  302 Comparing the aldehyde dehydrogenase principle with the Kageyama procedure it is -much faster and can therefore be recorded at room temperature, -it uses NADH or NADPH of which the coefficient of absorbance il well defined (4), and -does not lead to an underestimation of the uric acid concentration in the presence of novaminsulfone. In a proceeding communication (9) it was shown that the TJV^method and the Kageyama procedure recovered only 80-97% of the uric acid concentration from protein-containing samples. This effect was attributed to the binding capacity of serum proteins for uric acid, which in vitro depends on temperature, ionic strength, pH-value and the concentration of proteins, uric acid or some drugs (14) (15) (16) (17) .
It must be assumed that the proportion of uric acid bound to serum proteins, which is not determined by the methods mentioned above, varies either in the presence of specific drugs, or under pathological conditions which may affect the binding capacity. Therefore new methods for the determination of the uric acid concentration should avoid this protein related effect. With the procedure using aldehyde dehydrogenase as proposed above more than 99% of the uric acid was recovered, which shows that the binding capacity of serum proteins is less effective under the conditions used.
Further H 2 0 2 producing reactions which are of interest in clinical chemistry are the cholesterol oxidase-, the glucose oxidase-and the xanthine oxidase reaction, which can be determined by using the aldehyde dehydrogenase principle in the same way as described above. Reports on these procedures will follow in separate communications. 
